On October 28, 2026, the Company, held the Special Meeting to consider certain proposals related to the Agreement and Plan of Merger, dated as of August 10, 2026 (the “Merger Agreement”), by and among the Company, Teledyne Technologies Incorporated, a Delaware corporation (“Parent”), and Detect Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”). The Merger Agreement provides for the acquisition of the Company by Parent by means of a merger of Merger Sub with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent. As of the close of business on September 16, 2026, the record date for the Special Meeting, there were 42,463,446 shares of the Company’s common stock, par value $0.01 per share (“Company Common Stock”), outstanding and entitled to vote at the Special Meeting, each of which was entitled to one vote per share with respect to each proposal voted on at the Special Meeting.
|
Varex Imaging Corporation is a manufacturer of X-ray imaging components, software, and systems. The company operates two segments: Medical and Industrial. In the Medical segment, it produces X-ray tubes, flat panel and photon counting detectors, high voltage connectors, image-processing software, and workstations for applications including computed tomography, mammography, oncology, and dental imaging. In the Industrial segment, it supplies Linatron X-ray linear accelerators, non-intrusive cargo inspection systems, and components for security screening, nondestructive testing, and irradiation. Varex serves global OEMs, government agencies, and system integrators across the Americas, EMEA, and APAC regions. Key customers include Canon Medical Systems, United Imaging Healthcare, General Electric, Siemens Healthineers, and Rapiscan Systems. The company was created on January 1, 2017, as a spin-off from Varian Medical Systems, with roots tracing back to the 1930s through Eimac Products and Varian Associates. Summarised from the company's own disclosures, fiscal year ended Nov 2025 |
Industry Medical Devices | Homepage vareximaging.com |
| Sector Healthcare | IR page vareximaging.com/investor-relations | |
|
Tags
x-ray tubes, flat panel detectors, photon counting detectors, linear accelerators, image processing software, cargo screening, nondestructive testing, medical imaging, security inspection, industrial quality control, Linatron, PaxScan, Snowbird, Claymount, MeVis, InfiMed
|
Press page vareximaging.com/news |
Metrics
| Valuation | |
|---|---|
| Market cap | $ 777.629M |
| Market cap (USD) | $ 777.629M |
| P/E | 35.48 |
| PEG | — |
| P/BV | 1.57 |
| P/S | 0.90 |
| P/OCF | 68.82 |
| P/FCF | -38.50 |
| Dividend yield | — |
| Turnover / mcap | — |
| Returns | |
|---|---|
| ROE | -14.0% |
| ROI | -8.4% |
| ROIC | -2.5% |
| Profit margin | -8.3% |
| Growth | |
|---|---|
| Revenue growing | No |
| Profits growing | No |
| Revenue up 3y | No |
| Revenue up 5y | No |
| Earnings growth 3y (net profit CAGR) | — |
| Quality | |
|---|---|
| Profitable | No |
| Margin expanding | No |
| Buying back stock | No |
| Diluting (TTM) | Yes |
| Debt/Equity | 69.9% |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 25 |
| Quality score | -70.6% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
| Figure | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 844.6M | 811M | 893.4M | 859.4M | 818.1M | 738.3M | 780.6M | 773.4M | 698.1M | 620.1M |
| Net profit | -70.3M | -47.7M | 48.2M | 30.3M | 17.4M | -57.9M | 15.5M | 27.5M | 51.6M | 68.5M |
| Free cash flow | 18.8M | 20.4M | 87.7M | -4.4M | 77.5M | -10.3M | 52.1M | 64.9M | 54.4M | 45.3M |
Filed figures
Lines the statements and their notes report beside the headline figures, read from the filings' XBRL as filed (no restatement applied), with figures computed from one filing's own lines. Cash-flow lines carry their cash direction: an outflow is negative. Each period links to its filing; a figure's period, report date and tag are in its tooltip.
| Figure | Sep 2016 | Sep 2017 | Sep 2018 | Sep 2019 | Sep 2020 | Sep 2021 | Sep 2022 | Sep 2023 | Sep 2024 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Balance sheet detail | ||||||||||
| Trade receivables (USD) | 122M | 164M | 154M | 141M | 124M | 155M | 173M | 164M | 158M | 157M |
| ↳ YoY growth | +33.9% | -5.9% | -8.4% | -12.2% | +25.4% | +11.6% | -5.6% | -3.6% | -0.7% | |
| ↳ 5y CAGR | +4.9% | +1.2% | +1.2% | +2.3% | +4.8% | |||||
| Borrowings, current (USD) | 0.00 | 20M | 25M | 30.7M | 2.5M | 2.8M | 2.1M | 1.5M | 46.3M | 1.5M |
| Borrowings, non-current (USD) | 0.00 | 464M | 365M | 364M | 453M | 432M | 412M | 441M | 397M | 366M |
| Lease liabilities (USD) | — | — | — | 0.00 | 29.8M | 25.4M | 22.3M | 27.2M | 33.3M | 34.4M |
| Cash and deposits (USD) | 36.5M | 83.3M | 51.9M | 29.9M | 101M | 145M | 89.4M | 153M | 169M | 145M |
| Intangible assets (USD) | 20.7M | 91.3M | 73.8M | 86.3M | 67.5M | 50.7M | 33.6M | 22.4M | 16.1M | 14M |
| Right-of-use assets (USD) | — | — | — | 0.00 | 27.7M | 24.3M | 23.2M | 29M | 28.3M | 29.4M |
| Net debt (borrowings + leases - cash) (USD) | -36.5M | 401M | 338M | 365M | 385M | 315M | 347M | 317M | 308M | 257M |
| Cash flow detail | ||||||||||
| Operating cash flow (USD) | 74.2M | 74.6M | 85.3M | 71.9M | 13.2M | 92.6M | 16.9M | 108M | 47.3M | 41.7M |
| Purchases of property, plant and equipment (USD) | -28.9M | -20.2M | -20.4M | -19.8M | -23.5M | -15.1M | -21.3M | -20.7M | -26.9M | -22.9M |
| Change in receivables (cash effect) (USD) | -4.6M | -23.1M | 9M | 14.8M | 17.7M | -32.9M | -18.1M | 9.8M | 6.7M | 100,000 |
| Change in inventories (cash effect) (USD) | -23.5M | -4.2M | -2.4M | -11.1M | -42.7M | 42.8M | -85M | 20.2M | 6.6M | -39.9M |
| Change in payables (cash effect) (USD) | -1.9M | 4.9M | 5.2M | -9M | 14.3M | -13.6M | 19.7M | -15M | -3.2M | 6.2M |
| Interest paid (cash effect) (USD) | 0.00 | -9.8M | -19.3M | -19.9M | -16.7M | -21.6M | -29.5M | -27.4M | -27.6M | -31.3M |
| Income taxes paid (cash effect) (USD) | 0.00 | -6M | -13.8M | -8.2M | -4.2M | -14.1M | -2.2M | -16.7M | -20.2M | -18.6M |
| Share-based compensation (USD) | 9.5M | 8.4M | 10M | 11.7M | 13.4M | 13.9M | 14M | 13.5M | 15.3M | 15M |
| Operating cash flow before change in receivables (USD) | 78.8M | 97.7M | 76.3M | 57.1M | -4.5M | 126M | 35M | 98.6M | 40.6M | 41.6M |
| Free cash flow (OCF - PPE - intangibles) (USD) | 45.3M | 54.4M | 64.9M | 52.1M | -10.3M | 77.5M | -4.4M | 87.7M | 20.4M | 18.8M |
| Income detail | ||||||||||
| Research and development expense (USD) | 53.5M | 67.3M | 83M | 78.1M | 78.9M | 71.9M | 77M | 84.8M | 87M | 91.1M |
| ↳ 5y CAGR | +9.4% | +6.1% | +2.7% | +0.4% | +2.2% | +2.9% | ||||
| Total comprehensive income (USD) | 69.1M | 52.8M | 33.3M | 8.3M | -54.9M | 17.1M | 30.9M | 47.4M | -48.9M | -72.2M |
| Comprehensive income to owners (USD) | 68.6M | 52.4M | 32.5M | 8M | -55.4M | 16.6M | 30.4M | 46.9M | -49.4M | -72.6M |
| Provision for credit losses (USD) | 100,000 | 400,000 | — | — | — | — | — | — | — | — |
| Credit cost ratio (credit losses / average receivables) (%) | — | 0.3% | — | — | — | — | — | — | — | — |
| Reported | Dec 13, 2017 | Dec 13, 2017 | Nov 27, 2018 | May 13, 2020 | Nov 30, 2020 | Nov 19, 2021 | Nov 18, 2022 | Nov 16, 2023 | Nov 19, 2024 | Nov 18, 2025 |
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpMaterial events reported to the SEC on Form 8-K or 6-K, newest first. The link opens the filing itself on EDGAR. Press releases from the company's own website, newest first.
On October 28, 2026, Varex Imaging Corporation, a Delaware corporation (the “Company”), held a special meeting of stockholders (the “Special Meeting”) to consider certain proposals related to the Agreement and Plan of Merger, dated as of August 10, 2026 (the “Merger Agreement”), by and among the Company, Teledyne Technologies Incorporated, a Delaware corporation (“Parent”), and Detect Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”). The Merger Agreement provides for the acquisition of the Company by Parent by means of a merger of Merger Sub with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent. As of the close of business on September 16, 2026, the record date for the Special Meeting, there were 42,463,446 shares of the Company’s common stock, par value $0.01 per share (“Company Common Stock”), outstanding and entitled to vote at the Special Meeting, each of which was entitled to one vote per share with respect to each proposal voted on at the Special Meeting.
As previously disclosed, on August 10, 2026, Varex Imaging Corporation, a Delaware corporation (“Varex” or the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Teledyne Technologies Incorporated, a Delaware corporation (“Parent”), and Detect Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”). The Merger Agreement provides for the acquisition of the Company by Parent by means of a merger of Merger Sub with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent.
In connection with the proposed Merger, and pursuant to the terms of the Merger Agreement, the Company filed with the Securities and Exchange Commission (the “SEC”) a definitive proxy statement on September 21, 2026 (the “Definitive Proxy Statement”) for the solicitation of proxies in connection with the special meeting of the Company’s stockholders (the “Special Meeting”) to be held virtually on October 28, 2026, at 4:30 p.m., Mountain Time, to vote upon, among other things, a proposal to adopt the Merger Agreement, as disclosed in the Definitive Proxy Statement.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Varex Imaging Corporation
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.
| ETF | Weight in ETF | Shares | Market value | As of |
|---|---|---|---|---|
| EVNT | 1.01% | 7,174 | $ 132.647K | Aug 31, 2026 |
| SMIZ | 0.58% | 86,091 | $ 1.592M | Aug 31, 2026 |
| SQLV | 0.29% | 8,038 | $ 83.836K | Jun 30, 2026 |
| FSEV | 0.14% | 870 | $ 9,074.10 | Jun 30, 2026 |
| MSSM | 0.14% | 52,104 | $ 963.403K | Aug 31, 2026 |
| FSML | 0.10% | 11,604 | $ 121.03K | Jun 30, 2026 |
| FESM | 0.08% | 432,850 | $ 4.515M | Jun 30, 2026 |
| IVSS | 0.04% | 1,051 | $ 10.962K | Jun 30, 2026 |
| PSC | 0.02% | 49,266 | $ 513.844K | Jun 30, 2026 |
| AVSC | 0.01% | 17,742 | $ 321.662K | Nov 16, 2026 |
| FSCC | 0.01% | 1,180 | $ 21.818K | Aug 31, 2026 |
| DFSV | 0.00% | 59,560 | $ 1.088M | Nov 12, 2026 |
| DFSU | 0.00% | 3,600 | $ 65.772K | Nov 12, 2026 |
| DFAS | 0.00% | 14,115 | $ 257.881K | Nov 12, 2026 |
| DCOR | 0.00% | 18,343 | $ 335.127K | Nov 12, 2026 |
| DFUS | 0.00% | 2,648 | $ 48.379K | Nov 12, 2026 |
| DFAC | 0.00% | 7,064 | $ 129.059K | Nov 12, 2026 |
| AVUS | 0.00% | 6,986 | $ 126.656K | Nov 16, 2026 |
| AVSU | 0.00% | 106 | $ 1,921.78 | Nov 16, 2026 |




In the M.4 Radiographic Testing session, Varex Imaging presented “Eliminating Artifacts and Boosting Efficiency with Varex TrueSpectrum™ Imaging” (Talk ID326), by Dr. Jonathan Schock with co-authors Martin Hu and Mike Stamm.
